Diagnostic Challenges in IC (and Male CPPS)
Status: | Completed |
---|---|
Conditions: | Chronic Pain, Psychiatric, Women's Studies, Pain, Urology |
Therapuetic Areas: | Musculoskeletal, Nephrology / Urology, Psychiatry / Psychology, Reproductive |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 2/4/2017 |
Start Date: | September 2003 |
End Date: | June 2011 |
The etiology and pathogenesis of interstitial cystitis (IC) and its related condition in
men, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has remained elusive. This
has hampered development of mechanistic treatment strategies for these common, chronic and
distressing medical conditions. We believe that IC and perhaps CP/CPPS are a spectrum of
complex but inter-related genetic and acquired diseases resulting from the interaction of
several genes regulating immune/inflammatory and neurogenic parameters and environmental
factors/circumstances or exposure, culminating in the combination of pain, frequency,
urgency and sexual specific symptoms. New research has delineated the dynamic and powerful
association of the immune and neurogenic system in pain activation. An immune-modulated
neurogenic model of IC illuminating the action of immune derived substances and pain related
substances might be important in discovering the determinants of pain, voiding dysfunction
and gender specific sexual problems. This inter-related dynamic model of IC disease
pathogenesis could be explored for potential avenues leading to novel diagnostic and
treatment strategies. We plan to identify and evaluate the sensitivity and specificity of
several novel nerve and inflammation related markers in the diagnosis and follow up of IC
(and CP/CPPS). By correlating the levels of urine immune and pain related substances to
disease mechanisms, severity and progression, we may be able to create a human disease
specific model for diagnosis and treatment.
men, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has remained elusive. This
has hampered development of mechanistic treatment strategies for these common, chronic and
distressing medical conditions. We believe that IC and perhaps CP/CPPS are a spectrum of
complex but inter-related genetic and acquired diseases resulting from the interaction of
several genes regulating immune/inflammatory and neurogenic parameters and environmental
factors/circumstances or exposure, culminating in the combination of pain, frequency,
urgency and sexual specific symptoms. New research has delineated the dynamic and powerful
association of the immune and neurogenic system in pain activation. An immune-modulated
neurogenic model of IC illuminating the action of immune derived substances and pain related
substances might be important in discovering the determinants of pain, voiding dysfunction
and gender specific sexual problems. This inter-related dynamic model of IC disease
pathogenesis could be explored for potential avenues leading to novel diagnostic and
treatment strategies. We plan to identify and evaluate the sensitivity and specificity of
several novel nerve and inflammation related markers in the diagnosis and follow up of IC
(and CP/CPPS). By correlating the levels of urine immune and pain related substances to
disease mechanisms, severity and progression, we may be able to create a human disease
specific model for diagnosis and treatment.
Inclusion Criteria:
- Participant has signed and dated the appropriate Informed Consent document.
- Participant must have had symptoms of discomfort or pain in the pelvic region for at
least a three (3) month period within the last six (6) months.
Exclusion Criteria:
- Major structural/anatomical urinary tract abnormalities
- Underlying inborn conditions
We found this trial at
1
site
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials